Navigation Links
Palomar Medical Technologies to Host First Quarter 2009 Financial Results Conference Call and Webcast on April 30, 2009
Date:4/23/2009

BURLINGTON, Mass., April 23 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, will hold its quarterly conference call of its 2009 first quarter financial results on Thursday, April 30, 2009 at 11:30 AM Eastern Time. If you would like to participate, please call (888) 419-5570 at 11:20 AM Eastern Time on that day. The telephone replay will be available one hour after the call at (888) 286-8010 passcode 65357877 and continue through Thursday, May 7, 2009.

A live webcast of Palomar's conference call will be available in the Investor Relations' section of the Company's web site www.palomarmedical.com. Institutional investors can access the call via Thomson Financial's password-protected event management site, StreetEvents (www.streetevents.com). The online archive will be available one hour after the call and continue through Thursday, May 7, 2009.

For more information on Palomar and its products, visit Palomar's website at www.palomarmedical.com. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the Investor Relations' section of the website.

About Palomar Medical Technologies Inc: Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In December 2006, Palomar became the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, light-based hair removal device. OTC clearance allows the product to be marketed and sold directly to consumers without a prescription. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons. Palomar is testing many new and exciting applications to further advance the hair removal market and other cosmetic applications. Palomar is focused on developing proprietary light-based technology for introduction to the mass markets. Palomar has granted The Procter & Gamble Company a non-exclusive License Agreement to certain patents, technology and FDA documents related to the home-use, light-based hair removal field for women. In addition, Palomar has an exclusive development and license agreement with Johnson & Johnson Consumer Companies to develop and potentially commercialize home-use, light-based devices for reducing or reshaping body fat including cellulite, reducing the appearance of skin aging, and reducing or preventing acne.

    Contacts:
    Kayla Castle
    Investor Relations Manager
    Palomar Medical Technologies, Inc.
    781-993-2411
    ir@palomarmedical.com


'/>"/>
SOURCE Palomar Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting
2. Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008
3. Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009
4. Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
5. Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program
6. Palomar Medical Reports Financial Results for Third Quarter 2008
7. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
8. Palomar to Unveil New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery
9. Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
10. Palomar to Debut New Technology at the American Academy of Dermatology Annual Meeting
11. Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2016)... PA (PRWEB) , ... December 11, 2016 , ... It’s ... nasal allergies that flare up. Tired of the sneezing, watery eyes and general discomfort ... solve this problem. , He then created a prototype of the patent-pending CLEAN AIR ...
(Date:12/10/2016)... ... December 09, 2016 , ... Even with breast cancer cited ... in recent years. This can be attributed to the improvement in breast cancer ... distributed. In response, Mediaplanet’s latest, cross-platform edition of “Breast Cancer Care” spotlights the ...
(Date:12/10/2016)... (PRWEB) , ... December 10, 2016 , ... ... presence in Harrisburg. PATS recently joined forces with other healthcare organizations to ... the State Capitol Rotunda in Harrisburg, featured a variety of speakers from around ...
(Date:12/9/2016)... MD (PRWEB) , ... December 09, 2016 , ... ... for counseling and aural rehabilitation—provided by audiologists—to remain a critical part of public ... Food and Drug Administration (FDA) announced this week that, starting immediately, ...
(Date:12/9/2016)... - Cincinnati, Ohio (PRWEB) , ... December 09, ... ... the production of miniature, folded, pharmaceutical inserts and outserts. As a means ... Device. This addition will enable Flottman to individually code professional inserts (PIs) ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DIEGO , Dec. 9, 2016  Forge ... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: ... targeting ,LpxC, for the treatment of bacterial infections ... has been recognized as an attractive antibacterial target ... a lack of suitable chemical starting points has ...
(Date:12/8/2016)... 2016  The global biosurgery market is expected to ... period of 2016 to 2021. The market is poised ... 18.21 billion in 2016. The market is primarily driven ... related injuries and spinal problems, increasing clearance of biosurgery ... blood loss management. In this report, the ...
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
Breaking Medicine Technology: